Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma

about

Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma

Item

http://www.wikidata.org/entity/Q58770993

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@en

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@nl

type

Item

label

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@en

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@nl

prefLabel

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@en

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@nl

P1476

Micropapillary or solid patter ...... h stage IB lung adenocarcinoma

@en

P2093

Chang Chen

http://www.w3.org/2001/XMLSchema#string

Chenyang Dai

http://www.w3.org/2001/XMLSchema#string

Chunyan Wu

http://www.w3.org/2001/XMLSchema#string

Dong Xie

http://www.w3.org/2001/XMLSchema#string

Huikang Xie

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Minglei Yang

http://www.w3.org/2001/XMLSchema#string

Minjie Ma

http://www.w3.org/2001/XMLSchema#string

Yijiu Ren

http://www.w3.org/2001/XMLSchema#string

Yunlang She

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Adjuvant chemotherapy for resected non-small cell lung cancer.

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller

P304

5384-5393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2018.08.64

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416786

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

chemotherapy

P932

6196197

http://www.w3.org/2001/XMLSchema#string